Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Amgen announced that its investigational KRASGC inhibitor sotorasib was granted Breakthrough Therapy Designation BTD by the Center for Drug Evaluation CDE of the National Medical Products Administration NMPA
OSE Immunotherapeutics announced a new collaboration agreement with MAbSilico a deep technology innovative TechBio located in Tours France to use artificial intelligence AIbased software for therapeutic monoclonal antibody drug development Nicolas Po...
Vertex Pharmaceuticals Incorporated announced that the US Food and Drug Administration FDA has cleared the IND enabling the company to proceed with initiating a clinical trial for VX an investigational stem cellderived fully differentiated pancreatic...
OmniSeq an innovator in next generation sequencing in oncology today announced its collaboration with the University of Pittsburgh Medical Center UPMC to employ its RNA sequencing RNAseq gene expression profile assay for selecting immunotherapy combi...
Takeda Pharmaceutical Company Limited announced new data from the Phase trial of mobocertinib TAK orally administered in previously treated patients with epidermal growth factor receptor EGFR Exon insertion metastatic nonsmall cell lung cancer mNSCL...
BioThera Solutions a commercialstage biopharmaceutical company today announced that the US Food and Drug Administration FDA has accepted its Biologics License Application BLA for BAT a proposed biosimilar to Avastin bevacizumab The FDA goal date set...
Almirall SA a global biopharmaceutical company based in Barcelona and Happify Health a leader in digital therapeutics solutions to improve mental and physical health based in New York will develop a version of its digital platform specifically for pe...
ADVANZ PHARMA Corp Limited ADVANZ PHARMA or the Company a specialty pharmaceutical company with a strategic focus on complex medicines in Europe today announced that its board of directors has reached an agreement on the terms of a cash offer to be m...
Antengene Corporation Limited Antengene SEHK HK a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestin class therapeutics in hematology and oncology announced that the N...
Q BioMed Inc announced that the US Food and Drug Administrations Office of Orphan Products Development has granted Orphan Drug Designation to UttrosideB a small molecule chemotherapeutic for the treatment of hepatocellular carcinoma HCC the most comm...
